FOLD - Amicus Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

FOLD is currently covered by 7 analysts with an average price target of $18.64. This is a potential upside of $4.37 (30.62%) from yesterday's end of day stock price of $14.27.

Amicus Therapeutics's activity chart (see below) currently has 159 price targets and 108 ratings on display. The stock rating distribution of FOLD is 87.5% BUY and 12.5% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 57.83% with an average time for these price targets to be met of 387.06 days.

Highest price target for FOLD is $16, Lowest price target is $9, average price target is $13.7.

Most recent stock forecast was given by JOSEPH SCHWARTZ from LEERINK on 29-Dec-2025. First documented stock forecast 20-Aug-2014.

Currently out of the existing stock ratings of FOLD, 7 are a BUY (87.5%), 1 are a HOLD (12.5%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 14-Jan-2022

$14.5

$0.23 (1.61%)

$14

1 months ago
(29-Dec-2025)

6/10 (60%)

$0.25 (1.75%)

465

Buy Since 04-Jan-2021

$14.5

$0.23 (1.61%)

$20

1 months 7 days ago
(22-Dec-2025)

4/10 (40%)

$3.61 (33.15%)

906

Buy Since 13-Apr-2021

$14.5

$0.23 (1.61%)

$21

1 months 10 days ago
(19-Dec-2025)

0/8 (0%)

$3.61 (33.15%)

Buy Since 18-Sep-2025

$14

1 months 10 days ago
(19-Dec-2025)

1/1 (100%)

$5.52 (65.09%)

96

Buy Since 19-Dec-2023

$12

6 months 12 days ago
(17-Jul-2025)

1/4 (25%)

$2.64 (28.21%)

375

Show more analysts

Please expand the browser size to see the chart

What is FOLD (Amicus Therapeutics) average time for price targets to be met?

On average it took 387.06 days on average for the stock forecasts to be realized with a an average price target met ratio 57.83

Which analyst has the current highest performing score on FOLD (Amicus Therapeutics) with a proven track record?

ELEMER PIROS

Which analyst has the most public recommendations on FOLD (Amicus Therapeutics)?

Elemer Piros has 6 price targets and 6 ratings on FOLD

Which analyst is the currently most bullish on FOLD (Amicus Therapeutics)?

Michael Ulz with highest potential upside - $10.73

Which analyst is the currently most reserved on FOLD (Amicus Therapeutics)?

Salveen Richter with lowest potential downside - -$5.27

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?